Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
GlaxoSmithKline PLC ADR
GS71Current price
17.49 EUR
+0.055 EUR (+0.32%)
Last closed
38.37 USD
Company
www.gsk.com
ISIN
US37733W2044
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
XETRA Stock Exchange
Capitalization
83 027 230 720 USD
Yield for 12 month
+7.36 %
1Y
3Y
5Y
10Y
15Y
GS71
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Address: 980 Great West Road, Brentford, United Kingdom, TW8 9GS
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
46.07 USDP/E ratio
13.57Dividend Yield
3.76 %Current Year
+40 564 001 188 USD
Last Year
+39 221 141 217 USD
Current Quarter
+10 544 928 296 USD
Last Quarter
+10 544 928 296 USD
Current Year
+28 424 761 054 USD
Last Year
+26 442 571 336 USD
Current Quarter
+7 761 570 130 USD
Last Quarter
+7 761 570 130 USD
Key Figures GS71
1 year
3 years
5 years
10 years
EBITDA
10 983 000 064 USD
Operating Margin TTM
PE Ratio
13.57
Return On Assets TTM
9.56 %
PEG Ratio
1.2559
Return On Equity TTM
33.3 %
Wall Street Target Price
46.07 USD
Revenue TTM
31 445 999 616 USD
Book Value
3.52 USD
Revenue Per Share TTM
Dividend Share
0.6 USD
Quarterly Revenue Growth YOY
9.8 %
Dividend Yield
3.76 %
Gross Profit TTM
19 917 000 000 USD
Earnings per share
3 USD
Diluted Eps TTM
3 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-28.2 %
Profit Margin
12.83 %
Dividend Analytics GS71
Dividend growth over 5 years
-16 %Continuous growth
–Payout Ratio 5 years average
68 %Dividend History GS71
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.53
Ex Dividend Date
16.08.2024
Forward Annual Dividend Yield
3.76 %
Last Split Factor
1226:1000
Payout Ratio
36.15 %
Last Split Date
22.07.2022
Dividend Date
10.10.2024
Stock Valuation GS71
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
13.57
Forward PE
8.5397
Enterprise Value Revenue
2.4376
Price Sales TTM
2.6403
Enterprise Value EBITDA
9.4786
Price Book MRQ
4.3388
Financials GS71
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GS71
For 52 weeks
32.44 USD
45.37 USD
50 Day MA
41.45 USD
Shares Short Prior Month
9 646 992
200 Day MA
41.1 USD
Short Ratio
3.53
Shares Short
11 693 251
Short Percent
0.72 %
BeatStart